 endovascular repair of
infrarenal aortic aneurysms using the Endurant stent graft.
J Vasc Surg 2014;59:1195-202.
652. Lowenthal D, Herzog L, Rogits B, Bulla K, Weston S, Meyer F,
et al. IdentiÔ¨Åcation of predictive CT angiographic factors in
the development of high-risk type 2 endoleaks after
endovascular aneurysm repair in patients with infrarenal
aortic aneurysms. Rofo 2015;187:49-55.
653. Ward TJ, Cohen S, Patel RS, Kim E, Fischman AM,
Nowakowski FS, et al. Anatomic risk factors for type-2
endoleak following EVAR: a retrospective review of preoperative CT angiography in 326 patients. Cardiovasc Intervent
Radiol 2014;37:324-8.
654. AbuRahma AF, Mousa AY, Campbell JE, Stone PA, Hass SM,
Nanjundappa A, et al. The relationship of preoperative
thrombus load and location to the development of type II
endoleak and sac regression. J Vasc Surg 2011;53:1534-41.
655. Bobadilla JL, Hoch JR, Leverson GE, Tefera G. The effect of
warfarin therapy on endoleak development after

endovascular aneurysm repair (EVAR) of the abdominal
aorta. J Vasc Surg 2010;52:267-71.
656. Beeman BR, Murtha K, Doerr K, McAfee-Bennett S,
Dougherty MJ, Calligaro KD. Duplex ultrasound factors
predicting persistent type II endoleak and increasing AAA
sac diameter after EVAR. J Vasc Surg 2010;52:1147-52.
657. Rayt HS, Sandford RM, Salem M, Bown MJ, London NJ,
Sayers RD. Conservative management of type 2 endoleaks
is not associated with